| Gene symbol | SIGLEC6 | Synonyms | CD327, CD33L, CD33L1, CD33L2, CDW327, OBBP1 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Description | sialic acid binding Ig like lectin 6 | ||||
| GTO ID | GTC3146 |
| Trial ID | NCT05488132 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | siglec-6 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | siglec-6 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML) |
| Year | 2022 |
| Country | China |
| Company sponsor | Xuzhou Medical University |
| Other ID(s) | XYFY2022-KL119-01 |
| Cohort 1 | |||||||||
|
|||||||||